102 related articles for article (PubMed ID: 21122850)
1. Antiplatelet therapy effectively reduces plasma plasminogen activator inhibitor-1 levels.
Sakata T; Kario K
Atherosclerosis; 2011 Feb; 214(2):490-1. PubMed ID: 21122850
[No Abstract] [Full Text] [Related]
2. Clopidogrel responsiveness in stroke patients on a chronic aspirin regimen.
Sternberg Z; Ching M; Sawyer RN; Chichelli T; Li F; Janicke D; Radovic V; Mehta B; Farooq O; Munschauer FE
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):725-32. PubMed ID: 22209644
[TBL] [Abstract][Full Text] [Related]
3. Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke.
Zhao L; Gray L; Leonardi-Bee J; Weaver CS; Heptinstall S; Bath PM
Platelets; 2006 Mar; 17(2):100-4. PubMed ID: 16421011
[TBL] [Abstract][Full Text] [Related]
4. Platelet aggregation and recruitment with aspirin-clopidogrel therapy.
Helgason CM; Grossi E; Pandey D; Valika A; Cursio J; Brace LD
Cerebrovasc Dis; 2008; 25(5):392-400. PubMed ID: 18349532
[TBL] [Abstract][Full Text] [Related]
5. Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke?
Ibrahim MM; Sebastian J; Hussain M; Al-Hussain F; Uchino K; Molina C; Khan K; Demchuk AM; Alexandrov AV; Saqqur M;
Cerebrovasc Dis; 2010; 30(5):508-13. PubMed ID: 20861622
[TBL] [Abstract][Full Text] [Related]
6. [Antiplatelet effects of combination therapy with low-dose aspirin and ticlopidine in cerebral ischemia].
Uchiyama S; Tsutsumi Y; Nagayama T; Kobayashi I; Maruyama S
Rinsho Shinkeigaku; 1989 May; 29(5):579-83. PubMed ID: 2791406
[TBL] [Abstract][Full Text] [Related]
7. The effect of aspirin, ticlopidine and their low-dose combination on platelet aggregability in acute ischemic stroke: a short duration follow-up study.
Akyuz A; Bolayir E; Dener S; Topalkara K; Topaktas S
Eur J Neurol; 1999 Jan; 6(1):57-61. PubMed ID: 10209351
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
[TBL] [Abstract][Full Text] [Related]
9. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
Pongrácz E
Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349
[TBL] [Abstract][Full Text] [Related]
10. Extended use of clopidogrel and aspirin after ischemic stroke.
Davis K; Dietrich E
Am J Health Syst Pharm; 2016 May; 73(10):611-2. PubMed ID: 27147209
[No Abstract] [Full Text] [Related]
11. Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.
Gurbel PA; Bliden KP; Fort JG; Jeong YH; Shuldiner A; Chai S; Gesheff T; Antonino M; Gesheff M; Zhang Y; Tantry US
Am Heart J; 2013 Feb; 165(2):176-82. PubMed ID: 23351820
[TBL] [Abstract][Full Text] [Related]
12. Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
Bernlochner I; Steinhubl S; Braun S; Morath T; Jaitner J; Stegherr J; Mehilli J; von Beckerath N; Schömig A; Kastrati A; Sibbing D
Thromb Haemost; 2010 Dec; 104(6):1193-200. PubMed ID: 20838744
[TBL] [Abstract][Full Text] [Related]
13. [Aggregation activity of platelets in various periods of ischemic stroke].
Shimokhina NIu; Petrova MM; Savchenko AA
Kardiologiia; 2010; 50(8):21-4. PubMed ID: 21105325
[TBL] [Abstract][Full Text] [Related]
14. Serial change in platelet activation markers with aspirin and clopidogrel after acute ischemic stroke.
Tsai NW; Chang WN; Shaw CF; Jan CR; Chang HW; Huang CR; Chen SD; Chuang YC; Lee LH; Lu CH
Clin Neuropharmacol; 2010; 33(1):40-5. PubMed ID: 19855266
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714
[No Abstract] [Full Text] [Related]
16. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Biller J
J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
[TBL] [Abstract][Full Text] [Related]
18. Dual antiplatelet therapy in ACS: time-dependent variability in platelet aggregation during the first week.
Guha S; Sardar P; Guha P; Deb S; Karmakar R; Chakraborti P; Mookerjee S; Deb PK; De R; Dutta A; Chaudhuri U
Indian Heart J; 2009; 61(2):173-7. PubMed ID: 20039503
[TBL] [Abstract][Full Text] [Related]
19. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
[TBL] [Abstract][Full Text] [Related]
20. [Thrombosis of pharmacoactive coronary endoprothesis after stopping antiplatelet treatment].
Saidi Y; Guesmi F; Landolsi M; Trabelsi S; Khemiri K; Ounalli K; Dziri C; Houissa M
Tunis Med; 2010 Jan; 88(1):63-4. PubMed ID: 20419882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
